Lamivudine Tablet, Film Coated
Product Images NDC 60687-720

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lamivudine (NDC 60687-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp72021

Lamivudine 150 mg film-coated oral tablets shown on a gray background with a millimeter scale for size reference. The oblong white tablet is imprinted with "APO" on one side and "LMV 150" divided by a vertical line on the other side.*

FDA Label Image

150 mg Lamivudine Tablet Blister (Blister)

Sheet of ten identical labels for Lamivudine Tablet, USP 150 mg oral film-coated tablets. Each label includes the product name, strength, generic name, lot number placeholder, expiration date placeholder, barcode, and labeler information: American Health Packaging, Columbus, OH 43217.*

FDA Label Image

150 mg Lamivudine Tablets Carton (Carton)

Lamivudine 150 mg film-coated tablets packaging label by American Health Packaging. The label shows 30 tablets (3 blisters of 10 tablets each). It includes storage instructions, dosage format, and a barcode. The product is marked Rx only and distributed by American Health Packaging, Columbus, Ohio.*

FDA Label Image

Figure 1. Virologic Response Through Week 48, Epv20001 (intent-to-treat) (Figure1)

A line graph showing the proportions of patients with HIV-1 RNA levels below 400 copies/mL over 48 weeks of treatment. Two treatment regimens with Lamivudine are compared: 150 mg twice daily and 300 mg once daily. The x-axis represents treatment time in weeks, while the y-axis represents the proportion of patients achieving the viral RNA threshold.*

FDA Label Image

Structural Formula (Structure)

Chemical structure diagram of Lamivudine showing its molecular arrangement including a heterocyclic base and a sugar-like moiety with sulfur and oxygen atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.